UTMD UTAH MEDICAL PRODUCTS INC

$66.47 +0.93%

Healthcare · Surgical & Medical Instruments & Apparatus

UTAH MEDICAL PRODUCTS INC (UTMD) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $212 million. Shares last traded at $66.47, 8.0% below their 52-week high. Over the past year the stock is up 23.3%. UTMD trades at a price-to-earnings ratio of 18.75, below the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 29.3%, above the peer median of -7.6%. Revenue declined 5.8% year over year.

Market Cap

$212M

Shares Out

3.2M

EPS (TTM)

$3.48

P/E Ratio

19.10

P/S Ratio

5.49

P/B Ratio

1.76

Dividend / Share

—

Dividend Yield

—

52-Week High

$72.25

52-Week Low

$52.35

Volume

Avg Vol (3m)

540.794

Performance

-3.59%

+4.28%

+3.94%

+13.54%

YTD

+17.87%

+23.33%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

48.22

SMA (50)

$66.60

SMA (200)

$62.31

Price vs SMA50

-0.20%

Price vs SMA200

+6.67%

ATR (14)

$2.02

Financials

Revenue

$39M

Net Income

$11M

Gross Margin

57.1%

Operating Margin

29.6%

Net Margin

29.3%

Return on Equity

9.4%

Return on Assets

9.1%

Current Ratio

28.64

Debt / Equity

0.00

Revenue Growth (YoY)

-5.8%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.82	2026-05-12
FY 2025	$3.48	2026-03-27
FY 2025	$0.82	2026-03-27
FY 2025	$0.94	2026-03-27
Q1 2026	$0.92	2026-05-12
FY 2025	$3.96	2026-03-27

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

UTMD vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers

18.75 / 28.73 med

-35% discount

P/S vs peers

5.49 / 2.52 med

+118% premium

Net margin vs peers

29.3% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.